Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine

Altice, 2011, HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: Results from a multisite study, Journal of Acquired Immune Deficiency Syndromes, 56, S22, 10.1097/QAI.0b013e318209751e

Altice, 2010, Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs, Lancet, 376, 367, 10.1016/S0140-6736(10)60829-X

Amato, 2005, An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research, Journal of Substance Abuse Treatment, 28, 321, 10.1016/j.jsat.2005.02.007

Bachireddy, 2013, Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine, Drug and Alcohol Dependence

Batki, 2002, A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users, Drug and Alcohol Dependence, 66, 283, 10.1016/S0376-8716(01)00208-3

Bojko, 2013, At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine, Addiction, 108, 1697, 10.1111/add.12243

Bruce, 2007, HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine – programme description and policy implications, International Journal of Drug Policy, 18, 326, 10.1016/j.drugpo.2006.12.011

Deiss, 2009, Tuberculosis and illicit drug use: Review and update, Clinical Infectious Diseases, 48, 72, 10.1086/594126

Dubrovina, 2008, Drug-resistant tuberculosis and HIV in Ukraine: A threatening convergence of two epidemics?, International Journal of Tuberculosis and Lung Disease, 12, 756

Getahun, 2012, Tuberculosis and HIV in people who inject drugs: Evidence for action for tuberculosis, HIV, prison and harm reduction services, Current Opinion in HIV and AIDS, 7, 345, 10.1097/COH.0b013e328354bd44

Glaziou, 2009, Global burden and epidemiology of tuberculosis, Clinics in Chest Medicine, 30, 621, 10.1016/j.ccm.2009.08.017

Gourevitch, 1996, Successful adherence to observed prophylaxis and treatment of tuberculosis among drug users in a methadone program, Journal of Addictive Diseases, 15, 93, 10.1300/J069v15n01_07

Granich, 2008, HIV and MDR-TB in Ukraine: News from a hazardous MDR-TB and HIV site, International Journal of Tuberculosis and Lung Disease, 12, 701

Hurley, 2010, How Ukraine is tackling Europe's worst HIV epidemic, British Medical Journal, 341, c3538, 10.1136/bmj.c3538

Izenberg, 2010, Next steps for Ukraine abolition of HIV registries, implementation of routine human immunodeficiency virus testing and expansion of services, Addiction, 105, 569, 10.1111/j.1360-0443.2009.02881.x

Janca, 1993, The ICD-10 symptom checklist: A companion to the ICD-10 classification of mental and behavioural disorders, Social Psychiatry and Psychiatric Epidemiology, 28, 239, 10.1007/BF00788743

Kruglov, 2008, The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007, Sexually Transmitted Infections, 84, i37, 10.1136/sti.2008.031195

Kruk, 2011, Tuberculosis among HIV-positive patients across Europe: Changes over time and risk factors, AIDS, 25, 1505, 10.1097/QAD.0b013e328348fafd

Mahmoudi, 1993, Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance, Journal of the American Medical Association, 270, 65, 10.1001/jama.1993.03510010071032

McLellan, 1980, An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index, Journal of Nervous and Mental Disease, 168, 26, 10.1097/00005053-198001000-00006

Mimiaga, 2010, “We fear the police, and the police fear us”: Structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine, AIDS Care, 22, 1305, 10.1080/09540121003758515

Ministry of Health of Ukraine, 2012

Niemi, 2003, Pharmacokinetic interactions with rifampicin: Clinical relevance, Clinical Pharmacokinetics, 42, 819, 10.2165/00003088-200342090-00003

Pablos-Mendez, 1997, Nonadherence in tuberculosis treatment: Predictors and consequences in New York City, American Journal of Medicine, 102, 164, 10.1016/S0002-9343(96)00402-0

Snyder, 1999, Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness, American Journal of Respiratory and Critical Care Medicine, 160, 178, 10.1164/ajrccm.160.1.9810082

Springer, 2012, Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners, PLoS One, 7, e38335, 10.1371/journal.pone.0038335

Story, 2007, Tuberculosis in London: The importance of homelessness, problem drug use and prison, Thorax, 62, 667, 10.1136/thx.2006.065409

Sylla, 2007, Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services, International Journal of Drug Policy, 18, 306, 10.1016/j.drugpo.2007.03.001

United States Department of State, 2011

Wolfe, 2010, Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward, Lancet, 376, 355, 10.1016/S0140-6736(10)60832-X

World Health Organization, 2011

World Health Organization, 2008